- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x EUJ: (2R)-3-{[(S)-hydroxy{[(1S,2R,3R,4S,5S,6R)-2,4,6-trihydroxy-3,5-bis(phosphonooxy)cyclohexyl]oxy}phosphoryl]oxy}propane-1,2-diyl dioctanoate(Non-covalent)
EUJ.5: 15 residues within 4Å:- Chain A: Y.95, K.103, K.107, R.109, K.110, P.111, C.112, K.113, L.359, L.363, R.366, S.367, R.370, Y.403, R.451
18 PLIP interactions:18 interactions with chain A- Hydrophobic interactions: A:L.359, A:L.359
- Hydrogen bonds: A:K.103, A:C.112, A:K.113, A:R.366, A:R.366, A:S.367, A:Y.403, A:R.451
- Salt bridges: A:K.103, A:K.107, A:R.109, A:K.113, A:K.113, A:R.366, A:R.366, A:R.370
EUJ.13: 15 residues within 4Å:- Chain B: Y.95, K.103, K.107, R.109, K.110, P.111, C.112, K.113, L.359, L.363, R.366, S.367, R.370, Y.403, R.451
17 PLIP interactions:17 interactions with chain B- Hydrophobic interactions: B:L.359
- Hydrogen bonds: B:K.103, B:C.112, B:K.113, B:R.366, B:R.366, B:S.367, B:Y.403, B:R.451
- Salt bridges: B:K.103, B:K.107, B:R.109, B:K.113, B:K.113, B:R.366, B:R.366, B:R.370
EUJ.20: 15 residues within 4Å:- Chain C: Y.95, K.103, K.107, R.109, K.110, P.111, C.112, K.113, L.359, L.363, R.366, S.367, R.370, Y.403, R.451
17 PLIP interactions:17 interactions with chain C- Hydrophobic interactions: C:L.359
- Hydrogen bonds: C:K.103, C:C.112, C:K.113, C:R.366, C:R.366, C:S.367, C:Y.403, C:R.451
- Salt bridges: C:K.103, C:K.107, C:R.109, C:K.113, C:K.113, C:R.366, C:R.366, C:R.370
EUJ.27: 15 residues within 4Å:- Chain D: Y.95, K.103, K.107, R.109, K.110, P.111, C.112, K.113, L.359, L.363, R.366, S.367, R.370, Y.403, R.451
17 PLIP interactions:17 interactions with chain D- Hydrophobic interactions: D:L.359
- Hydrogen bonds: D:K.103, D:C.112, D:K.113, D:R.366, D:R.366, D:S.367, D:Y.403, D:R.451
- Salt bridges: D:K.103, D:K.107, D:R.109, D:K.113, D:K.113, D:R.366, D:R.366, D:R.370
- 4 x 01: N4-(3-chloranyl-2-piperidin-1-yl-phenyl)-N1,N1-dimethyl-benzene-1,4-disulfonamide
01.6: 15 residues within 4Å:- Chain A: C.477, V.480, A.481, Y.484, S.509, F.513, I.516, F.553, V.557, L.558, F.561
- Chain D: Y.547, S.551, Y.555
- Ligands: R16.30
6 PLIP interactions:5 interactions with chain A, 1 interactions with chain D- Hydrophobic interactions: A:V.480, A:V.480, A:Y.484, A:F.513, A:F.561, D:Y.547
01.12: 15 residues within 4Å:- Chain A: Y.547, S.551, Y.555
- Chain B: C.477, V.480, A.481, Y.484, S.509, F.513, I.516, F.553, V.557, L.558, F.561
- Ligands: R16.9
6 PLIP interactions:5 interactions with chain B, 1 interactions with chain A- Hydrophobic interactions: B:V.480, B:V.480, B:Y.484, B:F.513, B:F.561, A:Y.547
01.19: 15 residues within 4Å:- Chain B: Y.547, S.551, Y.555
- Chain C: C.477, V.480, A.481, Y.484, S.509, F.513, I.516, F.553, V.557, L.558, F.561
- Ligands: R16.16
6 PLIP interactions:5 interactions with chain C, 1 interactions with chain B- Hydrophobic interactions: C:V.480, C:V.480, C:Y.484, C:F.513, C:F.561, B:Y.547
01.26: 15 residues within 4Å:- Chain C: Y.547, S.551, Y.555
- Chain D: C.477, V.480, A.481, Y.484, S.509, F.513, I.516, F.553, V.557, L.558, F.561
- Ligands: R16.23
6 PLIP interactions:5 interactions with chain D, 1 interactions with chain C- Hydrophobic interactions: D:V.480, D:V.480, D:F.513, D:F.561, C:Y.547
- pi-Stacking: D:Y.484
- 8 x HEX: HEXANE(Non-covalent)
HEX.7: 4 residues within 4Å:- Chain A: C.101, L.114, Y.452, F.456
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:L.114, A:Y.452, A:F.456
HEX.8: 3 residues within 4Å:- Chain A: L.453, F.456, Y.459
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:L.453, A:F.456
HEX.14: 4 residues within 4Å:- Chain B: C.101, L.114, Y.452, F.456
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:L.114, B:Y.452, B:F.456
HEX.15: 3 residues within 4Å:- Chain B: L.453, F.456, Y.459
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:L.453, B:F.456
HEX.21: 4 residues within 4Å:- Chain C: C.101, L.114, Y.452, F.456
3 PLIP interactions:3 interactions with chain C- Hydrophobic interactions: C:L.114, C:Y.452, C:F.456
HEX.22: 3 residues within 4Å:- Chain C: L.453, F.456, Y.459
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:L.453, C:F.456
HEX.28: 4 residues within 4Å:- Chain D: C.101, L.114, Y.452, F.456
3 PLIP interactions:3 interactions with chain D- Hydrophobic interactions: D:L.114, D:Y.452, D:F.456
HEX.29: 3 residues within 4Å:- Chain D: L.453, F.456, Y.459
2 PLIP interactions:2 interactions with chain D- Hydrophobic interactions: D:L.453, D:F.456
- 4 x R16: HEXADECANE(Non-covalent)
R16.9: 4 residues within 4Å:- Chain A: Q.532, Y.547
- Chain B: S.506
- Ligands: 01.12
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:Y.547
R16.16: 4 residues within 4Å:- Chain B: Q.532, Y.547
- Chain C: S.506
- Ligands: 01.19
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:Y.547
R16.23: 4 residues within 4Å:- Chain C: Q.532, Y.547
- Chain D: S.506
- Ligands: 01.26
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:Y.547
R16.30: 4 residues within 4Å:- Chain A: S.506
- Chain D: Q.532, Y.547
- Ligands: 01.6
1 PLIP interactions:1 interactions with chain D- Hydrophobic interactions: D:Y.547
- 8 x OCT: N-OCTANE(Non-covalent)(Non-functional Binders)
OCT.10: 3 residues within 4Å:- Chain A: V.399, G.401, W.402
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:W.402
OCT.11: 0 residues within 4Å:- (No contacts)
No protein-ligand interaction detected (PLIP)OCT.17: 3 residues within 4Å:- Chain B: V.399, G.401, W.402
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:W.402
OCT.18: 0 residues within 4Å:- (No contacts)
No protein-ligand interaction detected (PLIP)OCT.24: 3 residues within 4Å:- Chain C: V.399, G.401, W.402
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:W.402
OCT.25: 0 residues within 4Å:- (No contacts)
No protein-ligand interaction detected (PLIP)OCT.31: 3 residues within 4Å:- Chain D: V.399, G.401, W.402
1 PLIP interactions:1 interactions with chain D- Hydrophobic interactions: D:W.402
OCT.32: 0 residues within 4Å:- (No contacts)
No protein-ligand interaction detected (PLIP)- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Reeks, J. et al., Enabling High Throughput Electron Cryo-microscopy for Structure-based Design. To Be Published
- Release Date
- 2025-06-04
- Peptides
- Mucolipin-1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x EUJ: (2R)-3-{[(S)-hydroxy{[(1S,2R,3R,4S,5S,6R)-2,4,6-trihydroxy-3,5-bis(phosphonooxy)cyclohexyl]oxy}phosphoryl]oxy}propane-1,2-diyl dioctanoate(Non-covalent)
- 4 x 01: N4-(3-chloranyl-2-piperidin-1-yl-phenyl)-N1,N1-dimethyl-benzene-1,4-disulfonamide
- 8 x HEX: HEXANE(Non-covalent)
- 4 x R16: HEXADECANE(Non-covalent)
- 8 x OCT: N-OCTANE(Non-covalent)(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Reeks, J. et al., Enabling High Throughput Electron Cryo-microscopy for Structure-based Design. To Be Published
- Release Date
- 2025-06-04
- Peptides
- Mucolipin-1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.